Clinical Trial Update: Masitinib in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for masitinib in patients with mild to moderate Alzheimer's disease (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED